Carbamazepine Extended-Release for the Treatment of Bipolar Depression

NCT00203567 Phase 4 COMPLETED

To study the efficacy and safety of beaded extended-release Carbamazepine (Equetro) in the treatment of patients with Bipolar Disorder with a Major Depressive Episode.

Details

Lead sponsor	Tuscaloosa Research & Education Advancement Corporation
Phase	Phase 4
Status	COMPLETED
Enrolment	25
Start date	2005-08
Completion	2008-05

Conditions

• Bipolar Depression

Interventions

• carbamazepine ER

Primary outcomes

• To study the efficacy and safety of beaded extended-release Carbamazepine (Equetro) in the treatment of patients with Bipolar Disorder with a Major Depressive Episode. — 8 weeks

Countries

United States